drugset / Trial / NCT07358520
Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is a prospective, multicenter, parallel-controlled clinical trial designed to evaluate the therapeutic efficacy of Huaier Granules for proteinuria occurring in lung cancer patients undergoing treatment with either Bevacizumab or Anlotinib.
Timeline
- Start
- 2026-01-28
- Primary completion
- 2027-01-28
- Completion
- 2028-01-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bevacizumab | Monoclonal antibody | — | — |
| Comparator | Catequentinib | Small molecule | — | — |
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 10 g | Oral |